Update on recent preclinical and clinical studies of T790M mutant-specific irreversible epidermal growth factor receptor tyrosine kinase inhibitors

Overview of attention for article published in Journal of Biomedical Science, December 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

patent: 1 patent

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 42 Dimensions

Readers on

mendeley: 61 Mendeley

Summary Patents Wikipedia Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

Treatment of EGFR-driven cancer with fewer side effects

Grant US-11395821-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.